Cleared Special

K231925 - MINIMA S System

K231925 is the FDA 510(k) clearance for MINIMA S System by Lima Corporate S.P.A.. It is a Class 2 Orthopedic device (product code LZO) cleared through the Special 510(k) pathway after a 11-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
11d
Days
Class 2
Risk

K231925 is an FDA 510(k) clearance for the MINIMA S System. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Lima Corporate S.P.A. (Villanova Di San Daniele Del Friuli, IT). The FDA issued a Cleared decision on July 11, 2023 after a review of 11 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Lima Corporate S.P.A. devices

Submission Details

510(k) Number K231925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2023
Decision Date July 11, 2023
Days to Decision 11 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 122d · This submission: 11d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 419
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K231925.
Novae® Dual Mobility System, Hype® Hip System
K223745 · Serf · Dec 2023
Actinia® hip stems
K232371 · Implantcast GmbH · Oct 2023
EMPHASYS Femoral Stems
K233233 · Depuy Ireland UC · Oct 2023
BethaLoc® stem cementless HA
K223103 · Implantcast GmbH · Jun 2023
Xerxes Hip Stem
K231109 · Xerxes Arthopedix, LLC · Jun 2023
Exactech® Alteon® Short Tapered Wedge
K221323 · Exactech, Inc. · May 2023